This randomized clinical trial compares outcomes of standard chemotherapy and cetuximab combination therapy with vs without motolimod in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
https://ift.tt/2M9KSwp
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: January–February 2018 Source: Materials Today, Volume 21, Issue 1 Author(s): David Bradley http://ift.tt/2BP...
-
http://ift.tt/2sxENoo
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου